{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:54:28Z","timestamp":1775202868876,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vaccine.2026.128312","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:15:49Z","timestamp":1770311749000},"page":"128312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use cases for pan-sarbecovirus vaccines: a workshop report"],"prefix":"10.1016","volume":"76","author":[{"given":"Emily A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Malhame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Malvolti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saket","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela K.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia T.","family":"Ostrowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek F.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Osterholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve M.","family":"Lackritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128312_bb0005","series-title":"World Health Organ n.d","author":"WHO COVID-19 Dashboard","year":"2026"},{"key":"10.1016\/j.vaccine.2026.128312_bb0010","series-title":"Finance for an Equitable Recovery","first-page":"2022","volume":"1 of 2","author":"World Development Report","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128312_bb0015","series-title":"The development of pan-sarbecovirus vaccines - Next steps","author":"Advancing","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128312_bb0020","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(23)01775-0","article-title":"The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation","volume":"402","author":"Dzau","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128312_bb0025","series-title":"Meeting Summary. Oslo, Norway: Coalition for Epidemic Preparedness Innovations","author":"CEPI SAC","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128312_bb0030","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/vaccines13101075","article-title":"Improving the Suitability of Vaccine Design for Immunisation Programmes and Enhancing Vaccine Policy Quality Through User Research","volume":"13","author":"Malvolti","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128312_bb0035","series-title":"Evidence Considerations for Vaccine Policy Development (ECVP)","author":"WHO","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128312_bb0040","author":"WHO"},{"key":"10.1016\/j.vaccine.2026.128312_bb0045","unstructured":"Grading n.d. https:\/\/www.who.int\/emergencies\/grading (accessed January 8, 2026)."},{"key":"10.1016\/j.vaccine.2026.128312_bb0050","series-title":"Values framework for the allocation and prioritization of COVID-19 vaccination","author":"WHO SAGE","year":"2020"},{"key":"10.1016\/j.vaccine.2026.128312_bb0055","first-page":"2022","year":"2022","journal-title":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.128312_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.558270","article-title":"Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States","volume":"12","author":"Shih","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128312_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258462","article-title":"Individual determinants of COVID-19 vaccine hesitancy","volume":"16","author":"Gerretsen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128312_bb0070","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128312_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adm7471","article-title":"Improving vaccine equity by increasing vaccine thermostability","author":"Hare","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.128312_bb0080","first-page":"33","article-title":"Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries","author":"Karp","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128312_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00753-4","article-title":"A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity","volume":"8","author":"Adam","year":"2023","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.128312_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2059310","article-title":"Multi-dose vials versus single-dose vials for vaccination: perspectives from lower-middle income countries","volume":"18","author":"Basu","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128312_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-42349-5","article-title":"An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models","volume":"14","author":"Yuen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128312_bb0100","first-page":"10","article-title":"A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross-Protection Activity against Multiple SARS-CoV-2 Sublineages","author":"Zhang","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.vaccine.2026.128312_bb0105","first-page":"40","article-title":"Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine","author":"Pitcovski","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128312_bb0110","first-page":"11","article-title":"Skin patch delivery of a SARS-CoV-2 spike DNA vaccine produces broad neutralising antibody responses","author":"McMillan","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.vaccine.2026.128312_bb0115","first-page":"1","article-title":"mRNA Technology Transfer Hub and Intellectual Property: Towards a more Equitable and Sustainable Model","author":"Adekola","year":"2025","journal-title":"World Trade Rev"},{"key":"10.1016\/j.vaccine.2026.128312_bb0120","first-page":"41","article-title":"A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy","author":"Moore","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128312_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-025-63399-x","article-title":"Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic","volume":"16","author":"Whittaker","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128312_bb0130","series-title":"CIDRAP","author":"Coronavirus Vaccine Technology Landscape","year":"2022"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:46:05Z","timestamp":1775195165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"alternative-id":["S0264410X26001209"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128312","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use cases for pan-sarbecovirus vaccines: a workshop report","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128312"}}